Switching from semaglutide to tirzepatide or vice versa without proper dose adjustment can lead to suboptimal blood sugar control or increased side effects such as nausea, vomiting, or hypoglycemia
These concerns stem from early animal studies and human reports suggesting that semaglutide drugs may stimulate abnormal cell growth in the thyroid or pancreas
A single-pulse sequence was applied to acquire dynamic DMRS spectra from the mouse brain with the following parameters: 2 KHz bandwidth, 512 data points for the free induction decay (FID), 64 flip angle, 350 ms repetition time (TR) with 800 averages (5 min per spectrum) and a total of 15 spectra
After propensity score matching, the analytic cohort comprised 26,408 matched patients: 13,204 users and 13,204 non-users
The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease